Browsing Tag
biomanufacturing
3 posts
CSL (ASX:CSL) breaks ground on $1.5bn Kankakee plasma plant expansion, betting patented Horizon 2 technology can widen its immunoglobulin lead
CSL (ASX:CSL) breaks ground on a $1.5B Kankakee plasma plant expansion using patented Horizon 2 yield tech. Read the full strategic analysis.
Amgen (NASDAQ: AMGN) expands TrumpRx pricing deal, offers Aimovig and Amjevita at $299
Amgen cuts U.S. drug prices for Aimovig and Amjevita under TrumpRx, citing earlier investments in Ohio and North Carolina. See what this signals for big pharma.
Angel Yeast expands biomanufacturing with new Yichang plant and fermentation platform
Angel Yeast ramps up specialty yeast output and fermentation R&D with new 8,500-ton facility and pilot platform. Find out how it fuels brewing innovation.